Hikma delivers strong H1 performance and raises Generics guidance Growth in all three businesses and across all geographies 4 min read Editor's Pick Hikma delivers strong H1 performance and raises Generics guidance Growth in all three businesses and across all geographies AETOSWire August 3, 2023 Hikma Pharmaceuticals PLC and its subsidiaries (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, report its interim results...Read More
